Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01002090

CERILLIANT™ Tizanidine-D4 Hydrochloride Solution, 100 μg/mL in Methanol (as free base), Sold by MilliporeSigma™ Supelco™

Catalog No. 01002090 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-002-090 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-002-090 Supplier MilliporeSigma Supelco Supplier No. T1201ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

This stable-labeled internal standard is suitable for quantitation of tizanidine levels in GC/MS or LC/MS methods for clinical toxicology, urine drug testing, pain prescription monitoring, forensic analysis or isotope dilution applications. Tizanidine, sold under the tradename Zanaflex™, is a skeletal muscle relaxant used for treatment of spasticity associated with multiple sclerosis, and for painful muscle spasms.
TRUSTED_SUSTAINABILITY

Specifications

CAS 67-56-1, 1188263-51-5
Linear Formula C9H4D4ClN5S · HCl
MDL Number MFCD09264522
UN Number UN 1230 - class 3 - PG 2 - Methanol, solution
Concentration 100 μg/mL in methanol (as free base)
Formula Weight 294.20
Packaging Ampule
Quantity 1 mL
Flash Point 9.7°C (49.5°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.